S&P 500 Futures
(0.25%) 5 144.50 points
Dow Jones Futures
(0.17%) 38 508 points
Nasdaq Futures
(0.34%) 17 906 points
Oil
(0.05%) $83.89
Gas
(0.78%) $1.938
Gold
(0.30%) $2 354.20
Silver
(0.59%) $27.70
Platinum
(2.03%) $940.85
USD/EUR
(-0.16%) $0.933
USD/NOK
(-0.32%) $10.99
USD/GBP
(-0.29%) $0.798
USD/RUB
(1.26%) $93.04

リアルタイムの更新: DVx Inc. [3079.T]

取引所: JPX セクター: Healthcare 産業: Medical Devices
最終更新日時26 4月 2024 @ 15:15

-0.50% ¥ 996.00

Live Chart Being Loaded With Signals

Commentary (26 4月 2024 @ 15:15):

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters...

Stats
本日の出来高 56 600.00
平均出来高 11 800.00
時価総額 10.40B
EPS ¥0 ( 2024-01-30 )
次の収益日 ( ¥0 ) 2024-05-13
Last Dividend ¥30.00 ( 2023-03-30 )
Next Dividend ¥0 ( N/A )
P/E 26.11
ATR14 ¥1.661 (0.17%)

ボリューム 相関

長: 0.14 (neutral)
短: -0.25 (neutral)
Signal:(46.626) Neutral

DVx Inc. 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

DVx Inc. 相関 - 通貨/商品

The country flag 0.27
( neutral )
The country flag 0.42
( neutral )
The country flag -0.42
( neutral )
The country flag 0.33
( neutral )
The country flag 0.33
( neutral )
The country flag 0.28
( neutral )

DVx Inc. 財務諸表

Annual 2022
収益: ¥47.48B
総利益: ¥5.46B (11.49 %)
EPS: ¥90.21
FY 2022
収益: ¥47.48B
総利益: ¥5.46B (11.49 %)
EPS: ¥90.21
FY 2022
収益: ¥45.50B
総利益: ¥5.34B (11.73 %)
EPS: ¥83.56
FY 2021
収益: ¥41.01B
総利益: ¥4.96B (12.09 %)
EPS: ¥55.60

Financial Reports:

No articles found.

DVx Inc. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
¥0
(N/A)
¥0
(N/A)
¥30.00
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)
¥0
(N/A)

DVx Inc. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.93 - average (97.64%) | Divividend Growth Potential Score: 3.61 - Decrease likely (27.84%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend ¥5.00 2010-03-29
Last Dividend ¥30.00 2023-03-30
Next Dividend ¥0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 15 --
Total Paid Out ¥229.63 --
Avg. Dividend % Per Year 0.00% --
Score 2.23 --
Div. Sustainability Score 6.93
Div.Growth Potential Score 3.61
Div. Directional Score 5.27 --
Next Divdend (Est)
(2024-12-31)
¥0 Estimate 0.00 %
Dividend Stability
0.05 Very Bad
Dividend Score
2.23
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
7912.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
7088.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
6378.T Ex Dividend Junior 2024-03-28 Annually 0 0.00%
5304.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
4368.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
3538.T Ex Dividend Knight 2023-12-28 Semi-Annually 0 0.00%
2763.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
9658.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%
8600.T Ex Dividend Junior 2023-09-28 Semi-Annually 0 0.00%
8182.T Ex Dividend Knight 2023-09-28 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.008611.5009.8310.00[0 - 0.5]
returnOnAssetsTTM0.01751.2009.4210.00[0 - 0.3]
returnOnEquityTTM0.04321.500-0.631-0.947[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.6170.8006.925.53[1 - 3]
quickRatioTTM1.4390.8006.244.99[0.8 - 2.5]
cashRatioTTM0.5631.5007.9810.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM3 364.071.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM82.272.0010.0010.00[0 - 30]
freeCashFlowPerShareTTM82.272.0010.0010.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.1071.000-1.548-1.548[0.2 - 0.8]
operatingProfitMarginTTM0.01831.000-1.634-1.634[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM2.030.80010.008.00[0.5 - 2]
Total Score6.93

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM26.161.0007.460[1 - 100]
returnOnEquityTTM0.04322.50-0.406-0.947[0.1 - 1.5]
freeCashFlowPerShareTTM82.272.0010.0010.00[0 - 30]
dividendYielPercentageTTM5.021.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM82.272.0010.0010.00[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM1.8331.5001.1140[0.5 - 2]
operatingCashFlowSalesRatioTTM0.01861.000-2.030[0.1 - 0.5]
Total Score3.61

DVx Inc.

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。